Sustained improvement of cognition and global function in patients with moderately severe Alzheimer’s disease:a double-blind, placebo-controlled study with the neurotrophic agent Cerebrolysin®

Author:

Ruether E.,Alvarez X. A.,Rainer M.,Moessler H.

Publisher

Springer Vienna

Reference25 articles.

1. Akai F, Hiruma S, Sato T et al (1992) Neurotrophic factor-like effect of FPF1070 on septal cholinergic neurons after transections of fimbria-fornix in the rat brain.Ristol Histopathol 7: 213–221

2. Bae C-Y, Cho C-Y, Cho K, Oh BH, Choi KG, Lee HS, Jung SP, Kim DH, Lee S, Choi G-D, Cho H, Lee H (2000) A double-blind, placebo-controlled, multicenter study of Cerebrolysin for Alzheimer’s disease.JAGS 48: 1566–1571

3. Erzigkeit H (1989) The SKT - a short cognitive performance test as an instrument for the assessment of clinical efficacy of cognitive enhancers.In: Bergner W, Reisberg B (eds) Diagnosis and treatment of senile dementia.Springer,Berlin Heidelberg New York Tokyo

4. Francis-Turner L, Valouskova V (1996) Nerve growth factor and nootropic drug Cerebrolysin but not fibroblast growth factor can reduce spatial memory impairment elicited by fimbria-fornix transection: short-term study.Neurosci Lett 202: 1–4

5. Folstein MF,Folstein SE,McHugh PR (1975) “Mini-Mental State”.A practical method for grading the cognitive state of patients for the clinician.J Psychiatr Res 12: 189–198

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3